Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by blackspade799on May 31, 2024 5:55pm
148 Views
Post# 36067061

New study shows cannabis terpenes may relieve chemotherapy

New study shows cannabis terpenes may relieve chemotherapyA University of Arizona Health Sciences study published in the journal Pain found that Cannabis sativa terpenes were as effective as morphine at reducing chronic neuropathic pain and a combination of the two analgesics further enhanced pain relief without negative side effects.

Some prior studies have shown that the Cannabis sativa plant and its two primary cannabinoids, tetrahydrocannabinol, or THC, and cannabidiol, or CBD, can be effective in managing chronic pain; however, the effects are generally moderate and can come with unwanted psychoactive side effects. Terpenes, the compounds that give plants their aroma and taste, offer an alternative path to pain relief without adverse side effects.

"A question that we've been very interested in is could terpenes be used to manage chronic pain?" said lead researcher John Streicher, Ph.D., a member of the Comprehensive Center for Pain & Addiction and a professor of pharmacology at the College of Medicine, Tucson. "What we found is that terpenes are really good at relieving a specific type of chronic pain with side effects that are low and manageable."

https://medicalxpress.com/news/2024-05-cannabis-terpenes-relieve-chemotherapy-neuropathic.html

<< Previous
Bullboard Posts
Next >>